Gavi and UNICEF welcome approval of new oral cholera vaccine

Gavi, the Vaccine Alliance and UNICEF welcome the news that a new oral cholera vaccine (OCV), Euvichol-S, has now received WHO prequalification and can be made available to countries around the world.

Brazilian Ministry of Health and Gavi reaffirm partnership to advance equitable immunisation globally

The Brazilian Ministry of Health (MoH) and Gavi, the Vaccine Alliance, have signed a landmark Memorandum of Understanding (MoU) to collaborate on vaccine production, innovation, and global access.

Global deployment of rapid diagnostic tests to boost fight against cholera

More than 1.2 million cholera rapid diagnostic tests will be shipped to 14 countries in largest-ever global deployment, with the first shipment landing today in Malawi.

Gavi increases support to reach all children with immunisation in the Central African Republic

Gavi to increase its financial support to strengthen data systems, bolster health workforce and engagement at community level, and foster innovation for enhancing outreach to better identify and reach missed children.

World Bank and partners to build on support for improved health and nutrition in Lao PDR

Over 7.5 million people from under-served rural areas in the Lao People’s Democratic Republic (PDR) will benefit from a US$ 62 million World Bank project to improve health and nutrition services.

France to co-host with African Union and Gavi the launch of the African Vaccine Manufacturing Accelerator (AVMA) and Gavi’s Investment Opportunity for 2026–2030

The high-level event, co-hosted in Paris on 20 June 2024 by the Government of France, the African Union and Gavi, together with Team Europe partners, will gather leaders from government, partner organisations, civil society and business across…

Gavi and Seedstars launch INFUSE 2024: a global open call for innovations to foster climate-resilient health systems

Gavi, the Vaccine Alliance, in partnership with Seedstars, announces INFUSE 2024: a global call for applications for innovations to bolster health systems against climate threats and to enhance immunisation delivery.

Vaccine Alliance outlines path to improve HPV vaccine market

A new Gavi market shaping roadmap for HPV vaccines showcases how partners, manufacturers and countries must work together to secure a sustainable supply over the next decade.

Wave of new commitments marks historic step towards the elimination of cervical cancer

New country, policy and program commitments, plus nearly US$600 million in new funding, at first-ever global forum offer a chance to save hundreds of thousands of lives by 2030.

Lao PDR receives over 650,000 doses of measles and rubella vaccine with support from Gavi

The Government of the Lao People’s Democratic Republic (PDR) has received over 650,000 doses of measles and rubella (MR) vaccine to help protect against and prevent the spread of the two illnesses, as part of Gavi’s support to the country’s…

PAHO and Gavi collaborate to inform countries about New Vaccine Introductions

The Pan American Health Organization (PAHO) and Gavi, the Vaccine Alliance (Gavi) will convene a three-day workshop in Saint Lucia on 26–28 February 2024, to review and discuss the new support that Gavi is giving to middle-income countries (MICs…

Nearly US$ 20 million made available to improve health care services through agreements between Government of Pakistan, Gavi and UNICEF

Ensuring that children, adolescents, and women, especially the most vulnerable, have access to quality and sustainable health services in Pakistan.

Last updated: 20 Nov 2023

Subscribe to our newsletter